Eunice Artis

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial

Peter Stein, Jolene Kay Berg, Linda Morrow et al. · Metabolism · 2014 · 47 citations · Full text

<scp>CCR2</scp> antagonism in patients with type 2 diabetes mellitus: a randomized, placebo‐controlled study

Nicholas A. Di Prospero, Eunice Artis, Patricia Andrade‐Gordon et al. · Diabetes Obesity and Metabolism · 2014 · 47 citations

1192MO Amivantamab monotherapy and in combination with lazertinib in post-osimertinib EGFR-mutant NSCLC: Analysis from the CHRYSALIS study

N. B. Leighl, Catherine A. Shu, Anna Minchom et al. · Annals of Oncology · 2021 · 31 citations

Amivantamab Monotherapy, Post-osimertinib Egfr-mutant Nsclc, Medicine +8

Rationale and design: The VALsartan In Diastolic Dysfunction (VALIDD) Trial: Evolving the management of diastolic dysfunction in hypertension

Rajesh Janardhanan, William Daley, Tasneem Z. Naqvi et al. · American Heart Journal · 2006 · 29 citations

Diastolic Dysfunction, Hypertension, Blood Pressure +7

P76.74 PAPILLON: Randomized Phase 3 Study of Amivantamab Plus Chemotherapy vs Chemotherapy Alone in EGFR Exon20ins NSCLC

Tanu Agrawal, Eunice Artis, John Xie et al. · Journal of Thoracic Oncology · 2021 · 13 citations · Full text

Medicine, Pharmacology, Pathology +8